Questions Surround Merck’s Withdrawal Of Keytruda Filing For Lung Cancer In EU

 
• By Ian Schofield
  
Merck has withdrawn its Keytruda NSCLC application in the EU
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet